Potential consequences of healthcare recommendations: A focus on the U.S. Preventive Services Task Force

Rohit Satoskar, Nancy Reau – 4 March 2013 – Healthcare guidelines and recommendations have broad‐reaching impact. They serve as the evidence to enforce medical testing by establishing a bar for standard of care through their intrinsic credibility but also by affecting reimbursement. In this article, we discuss the various organizations in the United States that develop healthcare policy and guidelines. We focus on the recent recommendations for hepatitis C virus (HCV) screening put forward by these agencies and the potential effect of these documents.

Persistent abnormal liver fibrosis after weaning off parenteral nutrition in pediatric intestinal failure

Annika Mutanen, Jouko Lohi, Päivi Heikkilä, Antti I. Koivusalo, Risto J. Rintala, Mikko P. Pakarinen – 4 March 2013 – The aim of this study was to evaluate the long‐term effects of pediatric intestinal failure (IF) on liver histology. Altogether, 38 IF patients (median age: 7.2 years; range, 0.2‐27) underwent liver biopsy, gastroscopy, abdominal ultrasound, and laboratory tests. Sixteen patients were on parenteral nutrition (PN) after 74 PN months (range, 2.5‐204). Twenty‐two had weaned off PN 8.8 years (range, 0.3‐27) earlier, after 35 PN months (range, 0.7‐250).

Overexpressed‐eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma

Yi‐Wei Wang, Kuen‐Tyng Lin, Shu‐Chuan Chen, De‐Leung Gu, Chian‐Feng Chen, Pang‐Hsien Tu, Yuh‐Shan Jou – 4 March 2013 – Eukaryotic translation initiation factor 3 subunit I (eIF3I) with transforming capability is often overexpressed in human hepatocellular carcinoma (HCC) but its oncogenic mechanisms remain unknown. We demonstrate that eIF3I is overexpressed in various cancers along with activated Akt1 phosphorylation and kinase activity in an eIF3I dose‐dependent manner.

Cellular‐specific role of toll‐like receptor 4 in hepatic ischemia‐reperfusion injury in mice

Gary W. Nace, Hai Huang, John R. Klune, Raymond E. Eid, Brian R. Rosborough, Sebastian Korff, Shen Li, Richard A. Shapiro, Donna B. Stolz, Chhinder P. Sodhi, David J. Hackam, David A. Geller, Timothy R. Billiar, Allan Tsung – 4 March 2013 – Ischemia‐reperfusion (I/R) injury is a process whereby an initial hypoxic insult and subsequent return of blood flow leads to the propagation of innate immune responses and organ injury. The necessity of the pattern recognition receptor, Toll‐like receptor (TLR)4, for this innate immune response has been previously shown.

Subscribe to